RVMD
Revolution Medicines IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$30.98B
P/E Ratio
—
EPS
$-7.11
Beta
1.41
52W High
$155.70
52W Low
$34.00
50-Day MA
$117.63
200-Day MA
$80.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Revolution Medicines Inc
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | 742,000 |
| Gross Profit (TTM) | $-1.13B |
| EBITDA | $-1.38B |
| Operating Margin | 0.00% |
| Return on Equity | -76.70% |
| Return on Assets | -37.50% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $8.28 |
| Price-to-Book | 20.11 |
| Price-to-Sales (TTM) | 9035.10 |
| EV/Revenue | 8370.02 |
| EV/EBITDA | -9.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -95.20% |
| Shares Outstanding | $212.60M |
| Float | $193.20M |
| % Insiders | 1.90% |
| % Institutions | 94.13% |
Historical Volatility
HV 10-Day
53.01%
HV 20-Day
60.35%
HV 30-Day
114.14%
HV 60-Day
83.85%
HV Rank
98.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($181.30 target)
4
Strong Buy17
BuyMore HEALTHCARE Stocks
Data last updated: 5/14/2026